ID   HeLa-EM2-11ht
AC   CVCL_WN71
SY   HeLa EM2-11ht
DR   Wikidata; Q94100654
RX   PubMed=19264799;
CC   Population: African American.
CC   Characteristics: Stably expresses an improved version of the reverse tetracycline controlled transactivator (rtTA2S-M2) under the control of the human EF1a promoter. Also express an hygromycin B phosphotransferase-thymidine kinase (HygTk) fusion gene as a positive/negative selection marker.
CC   Transfected with: UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transfected with: UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 05-10-23; Version: 7
//
RX   PubMed=19264799; DOI=10.1093/nar/gkp108;
RA   Weidenfeld I., Gossen M., Low R., Kentner D., Berger S., Gorlich D.,
RA   Bartsch D., Bujard H., Schonig K.;
RT   "Inducible expression of coding and inhibitory RNAs from retargetable
RT   genomic loci.";
RL   Nucleic Acids Res. 37:e50.1-e50.11(2009).
//